Zobrazeno 1 - 10
of 21
pro vyhledávání: '"FERNANDO GONGORA-RIVERA"'
Autor:
Erick A. Garcia-Valadez, Aldo Garcia-Heredia, Walter Muruet, Amaury Peñuelas, Fernando Gongora-Rivera
Publikováno v:
Revista Mexicana de Neurociencia, Vol 25, Iss 2 (2024)
Externí odkaz:
https://doaj.org/article/6326c47e747c4e9d9bb70c7ca0464314
Autor:
Sheila Cristina Ouriques Martins, Pablo Lavados, Thaís Leite Secchi, Michael Brainin, Sebastian Ameriso, Fernando Gongora-Rivera, Claudio Sacks, Carlos Cantú-Brito, Tony Fabian Alvarez Guzman, Germán Enrique Pérez-Romero, Mario Muñoz Collazos, Miguel A. Barboza, Antonio Arauz, Carlos Abanto Argomedo, Nelson Novarro-Escudero, Hector Ignacio Amorin Costabile, Roberto Crosa, Claudia Camejo, Ricardo Mernes, Nelson Maldonado, Daissy Liliana Mora Cuervo, Octávio Marques Pontes Neto, Gisele Sampaio Silva, Leonardo Augusto Carbonera, Ana Claudia de Souza, Eduardo David Gomes de Sousa, Alan Flores, Donoban Melgarejo, Irving R. Santos Carquin, Arnold Hoppe, João José Freitas de Carvalho, Francisco Mont'Alverne, Pablo Amaya, Hernan Bayona, Victor Hugo Navia González, Juan Carlos Duran, Victor C. Urrutia, Denizar Vianna Araujo, Valery L. Feigin, Raul G. Nogueira
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Introduction: Stroke is one of the leading causes of death in Latin America, a region with countless gaps to be addressed to decrease its burden. In 2018, at the first Latin American Stroke Ministerial Meeting, stroke physician and healthcare manager
Externí odkaz:
https://doaj.org/article/027d5df1b8fa4fc2b055e5d1de78c290
Autor:
Fernando Gongora-Rivera, Alejandro Gonzalez-Aquines, Juan Manuel Marquez-Romero, Neurological Endovascular Therapy – Mexican Group (NET-MX Group)
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Providing endovascular treatment (EVT) access for acute ischemic stroke (AIS) is a challenge in Latin America. Even though the Mexican Endovascular Reperfusion Registry (MERR) and the RESILIENT trial have demonstrated the feasibility of E
Externí odkaz:
https://doaj.org/article/fd0da3fe007d457cb6a080785cf63819
Autor:
Fernando Gongora-Rivera, Israel Grijalva, Adrian Infante-Valenzuela, Carlos Cámara-Lemarroy, Elvira Garza-González, Martin Paredes-Cruz, Concepción Grajales-Muñiz, José Guerrero-Cantera, Ignacio Vargas-Ramos, Jesus Soares, Joseph Y Abrams, Ashley R Styczynski, Adrián Camacho-Ortiz, Margarita E Villarino, Ermias D Belay, Lawrence B Schonberger, James J Sejvar, GBS HU-IMSS Working Group
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230132 (2020)
BackgroundBeginning August 2017, we conducted a prospective case-control investigation in Monterrey, Mexico to assess the association between Zika virus (ZIKV) and Guillain-Barré syndrome (GBS).MethodsFor each of 50 GBS case-patients, we enrolled 2-
Externí odkaz:
https://doaj.org/article/b57b87dd378642c098f0504c55c7a196
Autor:
Fernando Gongora-Rivera, Adolfo Cordero-Perez, Alejandro Gonzalez-Aquines, Antonio Anaya-Escamilla, Eduardo Villarreal-Garza, Meztli Espinosa-Ortega, Mario C. Salinas-Carmona, Xochilt Ortiz-Jimenez
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2018 (2018)
Background. Recent studies have shown that cerebral vascularity may be impaired in Alzheimer’s disease. Cerebral vasomotor reactivity could be an important biomarker for this pathology. Aims. The aim of this study was to investigate the alterations
Externí odkaz:
https://doaj.org/article/2ce14394f6db4901936568ce87d2e92a
Autor:
Alejandro Gonzalez-Aquines, Adolfo C. Cordero-Perez, Masoud Mohammadnezhad, Tomasz Bochenek, Fernando Gongora-Rivera
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 32:106972
Autor:
Marta Bilik, FERNANDO GONGORA-RIVERA, Waldemar Brola, Hrishikesh Kumar, Francesca romana Pezzella, Alessandro De Vito, Andrea Zini, Francisco Purroy, Danilo Toni, Vincent Thijs, Joan Martí-Fàbregas, Elena Reznik
Publikováno v:
JAMA Neurol
JAMA neurology
JAMA neurology, Vol. 78, no. 2, p. 1-9 (2020)
JAMA neurology
JAMA neurology, Vol. 78, no. 2, p. 1-9 (2020)
Importance Reduction of subsequent disabling stroke is the main goal of preventive treatment in the acute setting after transient ischemic attack (TIA) or minor ischemic stroke. Objective To evaluate the superiority of ticagrelor added to aspirin in
Autor:
Marta Bilik, FERNANDO GONGORA-RIVERA, Waldemar Brola, Francesca romana Pezzella, Alessandro De Vito, Francesco Perini, Andrea Zini, Peter Vanacker, Francisco Purroy, Anetta Lasek-Bal, Danilo Toni, Carlos Tejero-Juste, Vincent Thijs, Joan Martí-Fàbregas, Thierry Moulin, Elena Reznik, Yannick Béjot
Publikováno v:
The New England journal of medicine, Vol. 383, no. 3, p. 207-217 (2020)
The New England journal of medicine
The New England journal of medicine
BACKGROUND Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke or transient ischemic attack (TIA). In a previous trial, ticagrelor was not better than aspirin in preventing vascular events or death afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad52772821cb3f70be2bb6f13a82cf2
https://hdl.handle.net/2078.1/241346
https://hdl.handle.net/2078.1/241346
Autor:
Diego Alejandro Ortega-Moreno, Fernando Tienda-López, David Loaiza-Pérez, Fernando Chávez-Ríos, Samantha Salinas-Rodríguez, Egla Samantha Sánchez-Peralta, Ana Laura de León-Pérez, Diego Oyervides-Recio, Arely Rodríguez-Salazar, Emmanuel Navarrete Juárez, Fernando Góngora-Rivera
Publikováno v:
International Journal of Medical Students, Vol 11 (2023)
BACKGROUND: Stroke is highly prevalent worldwide; however, the associated symptoms and risk factors are commonly unknown among the general population. No study has been carried out in the Mexican population about the risk of stroke and knowledge of w
Externí odkaz:
https://doaj.org/article/ac2168d73fcb42f1ac0bbe7f967713b4
Autor:
Hector R Martinez, Hector Canfield Medina, Sergio Saldivar Davila, Juan M Escamilla Garza, Fernando Gongora Rivera, Alba Espino Ojeda
Publikováno v:
Journal of Alzheimer’s Disease & Parkinsonism.
Background: Abnormalities in cerebral vasomotor reactivity (CVR) in patients with idiopathic Parkinson’s disease (IPD) have not been well determined; nonetheless, a vascular mechanism may be involved in some patients with this neurodegenerative dis